Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $463.60 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $125.00 | 1 | $0 (2019) |
| GENZYME CORPORATION | $114.56 | 1 | $0 (2019) |
| UCB, Inc. | $113.29 | 1 | $0 (2018) |
| Acorda Therapeutics, Inc | $97.28 | 1 | $0 (2019) |
| AbbVie Inc. | $13.47 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $13.47 | 1 | AbbVie Inc. ($13.47) |
| 2019 | $336.84 | 3 | Teva Pharmaceuticals USA, Inc. ($125.00) |
| 2018 | $113.29 | 1 | UCB, Inc. ($113.29) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/07/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Central Nervous System | ||||||
| 05/07/2019 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $114.56 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 03/21/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Food and Beverage | Cash or cash equivalent | $97.28 | General |
| Category: PARKINSONS DISEASE | ||||||
| 12/03/2018 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $113.29 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 46 | 53 | $14,841 | $5,183 |
| 2021 | 8 | 315 | 4,752 | $135,973 | $54,315 |
| 2020 | 10 | 376 | 5,636 | $157,387 | $58,551 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 22 | $9,284 | $3,226 | 34.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 13 | $2,821 | $997.17 | 35.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 18 | $2,736 | $960.12 | 35.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 16 | 4,400 | $44,000 | $20,020 | 45.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 92 | 108 | $31,853 | $13,244 | 41.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 76 | 84 | $18,144 | $6,440 | 35.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 40 | 60 | $13,020 | $4,539 | 34.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 31 | 31 | $13,082 | $4,461 | 34.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 21 | 21 | $8,526 | $3,100 | 36.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 28 | 35 | $5,320 | $1,850 | 34.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 13 | $2,028 | $660.91 | 32.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 16 | 5,190 | $51,900 | $24,475 | 47.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 146 | 205 | $44,280 | $13,192 | 29.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 41 | 41 | $17,302 | $6,253 | 36.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 45 | 52 | $15,236 | $4,505 | 29.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 21 | 21 | $8,526 | $2,647 | 31.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 32 | 43 | $6,536 | $2,314 | 35.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 19 | 26 | $5,642 | $2,080 | 36.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 28 | 30 | $4,680 | $1,579 | 33.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 17 | 17 | $2,121 | $921.33 | 43.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 11 | 11 | $1,164 | $582.67 | 50.1% |
About Dr. Ruth Baird, MD
Dr. Ruth Baird, MD is a Neurology healthcare provider based in Avon, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1366650327.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ruth Baird, MD has received a total of $463.60 in payments from pharmaceutical and medical device companies, with $13.47 received in 2021. These payments were reported across 5 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($463.60).
As a Medicare-enrolled provider, Baird has provided services to 737 Medicare beneficiaries, totaling 10,441 services with total Medicare billing of $118,049. Data is available for 3 years (2020–2022), covering 21 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Avon, IN
- Active Since 05/21/2007
- Last Updated 11/24/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1366650327
Products in Payments
- AJOVY (Drug) $125.00
- AUBAGIO (Drug) $114.56
- Briviact (Drug) $113.29
- INBRIJA (Drug) $97.28
- UBRELVY (Drug) $13.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Avon
Christopher Wilson, Md, MD
Neurology — Payments: $437,965
Kylene Huler, M.d, M.D
Neurology — Payments: $4,416
Yolanda Pena, Md, MD
Neurology — Payments: $2,417
Muhammad Bilal, Md, MD
Neurology — Payments: $1,111
James Fesenmeier, Md, MD
Neurology — Payments: $651.62
Sadia Saba, Md, MD
Neurology — Payments: $95.30